JPRN-UMIN000034333已完成未知
The safety and efficacy of Lenvatinib for patients with unresectable hepatocellular carcinoma on practical medicine after the approval - The safety and efficacy Lenvatinib on practical medicine
ational Hospital Organization Kyoto Medical Center0 个研究点目标入组 500 人开始时间: 2019年1月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Pregnant woman Woman who may be pregnant
研究者
相似试验
招募中
Unknown
Efficacy and safety of lenvatinib for patients with advanced or recurrent thymic carcinoma: A real-world retrospective studynresectable advanced or recurrent thymic carcinomaJPRN-UMIN000051645Graduate School of Medicine, Chiba University80
招募中
不适用
The study of efficacy of lenvatinib in patients with hepatocellular carcinoma(HCC): Multicenter analysis.Hepatocellular carcinomaJPRN-UMIN000037054Yokohama City University Medical Center250
招募中
不适用
The safety and efficacy of nintedanib for patients with progressive fibrosing interstitial lung disease in a real world setting-a prospective observational studyProgressive fibrosing interstitial lung diseaseJPRN-UMIN000041380Department of Respiratory Medicine, Juntendo University Hospital300
已完成
不适用
Prognostic and predictive factors of lenvatinib in patients with hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000036625Kitasato University Hospital100
已完成
2 期
Lenvatinib in Patients With Previously Treated Advanced Biliary Tract CancerBiliary Tract CancerTargeted TherapyCholangiocarcinomaNCT04656249Peking Union Medical College Hospital46